BUILT Family Lifestyle Program for Children with ADHD
Launched by UNIVERSITY OF ILLINOIS AT CHICAGO · Jul 14, 2022
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
The BUILT Family Lifestyle Program is a clinical trial designed to help families with children who have Attention Deficit Hyperactivity Disorder (ADHD). This 8-week program aims to teach families how to create healthier routines related to food, sleep, and exercise, which are believed to improve children's focus and behavior. Families will learn about the best practices of successful athletes and thinkers and will test out different routines at home to see what works best for them. The researchers hope that by participating in this program, families will see positive changes in their child's health habits, ADHD symptoms, and overall family communication.
To join the study, children must be between 6 and 12 years old and enrolled in programs at the Chicago Park District. Parents need to attend an orientation session to learn about the program activities. Children should also be able to participate in physical activities without any health issues that would prevent them from doing so. This trial is currently looking for 150 families to participate, and it offers a great opportunity for families to improve their daily routines together while helping their child with ADHD.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Boys and girls ages 6 to 12 years old
- • Parent orientation session summarizing activities
- • Child free of conditions that preclude aerobic activity
- • Child enrolled in Chicago Park District programming
- Exclusion Criteria:
- • Boys and girls \< 6 years old or \> 12 years old
- • Parent does not participate in orientation session summarizing activities
- • Child has conditions that preclude aerobic activity
- • Child not enrolled in Chicago Park District programming
About University Of Illinois At Chicago
The University of Illinois at Chicago (UIC) is a leading academic institution renowned for its commitment to advancing health sciences through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, UIC harnesses the expertise of its diverse faculty and state-of-the-art facilities to conduct cutting-edge clinical studies aimed at improving patient outcomes. The university's robust infrastructure for clinical research, combined with its dedication to ethical standards and regulatory compliance, positions UIC as a pivotal contributor to the development of new treatments and therapies in various medical fields. Through strategic partnerships and community engagement, UIC strives to translate research findings into real-world applications, enhancing the health and well-being of populations locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Trial Officials
Eduardo E Bustamante, PhD
Principal Investigator
University of Illinois Chicago
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials